Does Perfusion with Treated Plasma Cure Cancer?

Abstract

Every now and then one reads reports that promise novel ways of treating cancer. Among the approaches used, those involving some aspects of immunology are rather common. In the early 1970s it was bacillus Calmette–Guérin (BCG); today it is interferon and various other "biologic-response modifiers" (among which BCG is no longer very popular). All of us hope, of course, that the promises are warranted, but we have often been disappointed in the past.The paper by Terman et al. in this issue¹ promises a new approach to cancer therapy, employing a technique that Dr. Terman and his colleagues were among . . .